JPMORGAN CHASE & CO

Position in FTRE — Fortrea Holdings Inc.

CIK 19617 NEW YORK, NY

Position in FTRE

as of Mar 31, 2026 · filed May 13, 2026 Compact

Position Value

$9,517,597

-$48,664 QoQ

Shares Held

1,010,361

+82.2% QoQ

Ownership

1.07%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2023

11 quarters on record

Voting authority Sole 92.8280089987638.ToString("F0")% Shared 0.ToString("F0")% None 7.171991001236192.ToString("F0")%

Healthcare · as of Mar 31, 2026

JPMORGAN CHASE & CO holds $16,578,690,346 across 405 Biotechnology names. FTRE ranks #77 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INSM	INSMED Inc	24,150,499	$3,949,089,591
2	REGN	Regeneron Pharmaceuticals, Inc.	4,311,806	$3,331,473,778
3	VRTX	Vertex Pharmaceuticals Inc / Ma	7,033,156	$3,140,585,469
4	ALNY	Alnylam Pharmaceuticals, Inc.	6,323,752	$2,092,339,815
5	NUVL	Nuvalent, Inc.	3,088,349	$316,401,351
6	JAZZ	Jazz Pharmaceuticals plc	1,204,353	$227,682,931
7	IONS	Ionis Pharmaceuticals Inc	2,363,567	$177,480,242
8	TERN	Terns Pharmaceuticals, Inc.	2,869,728	$151,292,056

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$9,517,597	1,010,361	+82.2%	Shares	Other	2026-05-13
2025-12-31	$9,566,261	554,566	-19.9%	Shares	Other	2026-02-11
2025-09-30	$5,832,548	692,702	+65.5%	Shares	Other	2025-11-26
2025-06-30	$2,067,352	418,493	+55.9%	Shares	Other	2025-08-12
2025-03-31	$2,026,394	268,397	+14.4%	Shares	Other	2025-05-12
2024-12-31	$4,374,353	234,550	-35.6%	Shares	Other	2025-02-12
2024-09-30	$7,288,260	364,413	+21.2%	Shares	Other	2024-12-26
2024-06-30	$7,017,097	300,647	+17.1%	Shares	Other	2024-12-26
2024-03-31	$10,308,509	256,814	-77.3%	Shares	Other	2024-12-26
2023-12-31	$39,437,834	1,130,024	+3.4%	Shares	Other	2024-12-26
2023-09-30	$31,241,746	1,092,751	—	Shares	Sole	2023-11-14
No filing history on record for this holder in this stock.